5 Must Have Features in an Oncology CRO

Navitas Life Sciences joins The World Health Organization in raising awareness about cervical cancer this January, Cervical Cancer Awareness Month. According to the WHO, 604,000 were affected with cervical cancer globally in 2020, and it is the fourth most common type of cancer. In the UK, around 3,200 new cervical cancer cases are identified every year, and is the 14th most common cancer (2016-2018). In the year 2023, projections indicated that there will be nearly 13,960 new incidences of invasive cervical cancer and the lives of nearly 4,310 American women may be lost to cervical cancer. This silent adversary takes a particularly severe toll on women's health in India, ranking as the second leading cause of cancer-related deaths among women in the country. In Indian women, 6 to 29% of all cancer cases are attributed to cervical cancer, with the highest incidence recorded in the state of Mizoram. The critical need for increased awareness and concerted action is undeniable.

During Cervical Cancer Awareness Month 2024, let's reiterate our dedication to facilitating efficient clinical trials expediting the availability of life-saving medicines in the market. The challenges in oncology clinical trials are formidable, given the unique patient populations, study design complexities, and special endpoints associated with these trials. Navitas Life Sciences’ expert team is dedicated to managing this complexity effectively.

In this blog post, we will explore five essential features to look for in an Oncology Clinical Trial Contract Research Organization (CRO). These handy insights will help you choose the best Oncology CRO.

1. Vast Oncology Clinical Trials Experience and Deep Therapeutic Expertise:

Oncology trials require a specialized understanding of the disease, patient populations, and evolving treatment modalities. A key feature to prioritize in an Oncology CRO is therapeutic expertise. At Navitas Life Sciences, our team boasts experts with vast experience and expertise, ensuring a deep understanding of oncology that is crucial for successful trial management.

An effective Oncology cro should have a broad spectrum of experience covering various indications and research phases. Navitas Life Sciences has a proven track record in managing over 600+ Clinical Trials across all phases, focusing on various targeted therapies across 20+ therapeutic areas. With 120,000 Patients in the last decade, across multiple sites globally and more than 25% of studies conducted in oncology, our clinical experience sets us apart in the field.

1000+ PROFESSIONALS

incl. Doctors, PhDs, Biostatisticians, Pharmacologists, etc

2. Global Oncology Clinical Studies and Reach:

The global nature of clinical trials necessitates a CRO with the capabilities to conduct studies worldwide. Navitas Life Sciences supports Clinical Trials globally, allowing us to facilitate study startup and execution seamlessly across the world. Whether it's highly specialized early phase oncology clinical trials, Phase I studies, or large-scale Phase III trials, our flexible services cover international regulatory submissions, participant inclusion, and comprehensive understanding of clinical and geographic aspects associated with global oncology research.

3. Artificial Intelligence and Other Stellar Digital Capabilities:

Oncology Clinical Research Organizations (CROs) require the integration of cutting-edge digital technologies and AI support. At Navitas Life Sciences, a leading CRO, the innovative OneClinical^® Analytics platform offers near real-time data insights throughout the trial, providing a robust tool to effectively navigate the challenges inherent in oncology research. Leveraging intelligent trial AI analytics enables proactive identification and resolution of critical issues early in the process, leading to optimized resource deployment, ultimately saving both time and costs. The synergy between AI and machine learning in clinical trials, coupled with Clinical Trial expertise, positions Navitas Life Sciences as a key player in advancing drug development and elevating patient outcomes.

OneClinical^® Analytics - Near Real Time Insights

4. Comprehensive Clinical Data Services:

In the era of data-driven insights, an Oncology CRO must offer comprehensive data services. Navitas Life Sciences specializes in data management, biostatistics, and medical writing. Our therapeutically focused stand-alone services, including pharmacovigilance, ensure that your oncology study's data is handled with precision.

5. Gaining Value through Patient Registries:

Patient registry studies play a crucial role in clinical research, including in oncology. Navitas Life Sciences has a wealth of experience in managing these programs efficiently. Our in-depth understanding of clinical registries, including managing for certain U.S Federal agencies, allows us to plan, launch, and manage them seamlessly.

Choosing the right Oncology CRO is paramount for the success of your clinical trials. Navitas Life Sciences, with its specialized Oncology team, stands out in addressing the unique challenges associated with oncology research. From therapeutic expertise to global capabilities and comprehensive data services, we offer a holistic solution to expedite the development of critically needed oncology products and contribute to the fight against cancer.

To know more about our services and solutions, reach out to us at This email address is being protected from spambots. You need JavaScript enabled to view it..